Boston Partners’s Aspen Aerogels ASPN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-71,984
Closed -$788K 624
2020
Q3
$788K Buy
71,984
+15,606
+28% +$123K ﹤0.01% 567
2020
Q2
$371K Sell
56,378
-34,094
-38% -$219K ﹤0.01% 630
2020
Q1
$556K Sell
90,472
-111,920
-55% -$908K ﹤0.01% 589
2019
Q4
$1.57M Buy
202,392
+56,888
+39% +$393K ﹤0.01% 533
2019
Q3
$861K Buy
145,504
+83,838
+136% +$533K ﹤0.01% 594
2019
Q2
$440K Buy
+61,666
New +$280K ﹤0.01% 644

Other funds holding ASPN

Boston Partners's ASPN Position: Q4 2020 in Review

Boston Partners sold out of Aspen Aerogels (ASPN) in Q4 2020, closing a stake of 71,984 shares — an estimated $788K sold.

Boston Partners first reported a position in ASPN in Q2 2019 and held it in 6 quarters. The position peaked at $1.57M in Q4 2019. 76 funds tracked by Wall St. Rank hold ASPN as of Q4 2020.

  • Boston Partners reported no remaining Aspen Aerogels position as of Q4 2020 after selling out during the quarter.
  • Boston Partners sold 71,984 Aspen Aerogels shares in Q4 2020, an estimated $788K.
  • Boston Partners first reported a position in Aspen Aerogels in Q2 2019 and held it in 6 quarters.
  • Boston Partners's Aspen Aerogels position peaked at $1.57M in Q4 2019.
  • 76 funds tracked by Wall St. Rank held Aspen Aerogels as of Q4 2020.

Based on Boston Partners's 13F filing for Q4 2020, filed 4 Feb 2021.